Is Crinetics Pharmaceuticals, Inc. (CRNX) a Buy, Sell, or Hold?
NASDAQ : CRNX
Crinetics Pharmaceuticals, Inc. — Institutional Ownership
$83.52 USD
-$0.11 (-0.13%)
- Volume
- 1.86M
- Average Volume
- 3.69M
- Market Capitalization
- $8.84B
- P/E Ratio
- -16.25
- Dividend Yield
- 0.00%
- Price Target
- $85.00
- Year High
- $84.00
- Year Low
- $25.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $18.60
Institutional Ownership Summary
Institutional Ownership %
3.46%
Investors Holding
52
change: -197 | last: 249
Increased Positions
25
change: -139 | last: 164
Reduced Positions
14
change: -46 | last: 60
New Positions
16
change: -31 | last: 47
Sold Positions
207
change: 156 | last: 51
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -105.0769 | last: 1.0508
Total Invested
134.95M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | DRIEHAUS CAPITAL MANAGEMENT LLC | 6.4M | 6.11% |
| 2026-05-15 | Wellington Management Group LLP | 8.16M | 7.80% |
| 2026-05-15 | T. Rowe Price Associates, Inc. | 5.36M | 5.10% |
| 2026-04-29 | Vanguard Capital Management | 5.44M | 5.19% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-05 | Farallon Capital Partners, L.P. | 584.53K | 0.60% |
| 2025-11-12 | Wellington Management Group LLP | 8.38M | 8.90% |
| 2025-09-08 | Farallon Capital Partners, L.P. | 397.73K | 0.40% |
| 2025-08-12 | Wellington Management Group LLP | 5.81M | 6.20% |
| 2025-05-12 | FMR LLC | 13.96M | 15.00% |
| 2025-04-07 | The Vanguard Group | 9.31M | 10.00% |
| 2025-02-10 | Wellington Management Group LLP | 6.95M | 7.50% |
| 2025-02-07 | FMR LLC | 9.63M | 10.40% |
| 2025-02-07 | FMR LLC | 8.9M | 9.60% |
| 2025-01-30 | The Vanguard Group | 9.09M | 9.80% |
| 2024-11-14 | 52-0556948 | 4.94M | 6.20% |
| 2024-11-08 | Wellington Investment Advisors Holdings LLP | 4.46M | 5.57% |
| 2024-11-08 | Wellington Management Group LLP | 4.46M | 5.57% |
| 2024-11-08 | Wellington Group Holdings LLP | 4.46M | 5.57% |
| 2024-11-08 | Wellington Management Company LLP | 4.16M | 5.20% |
| 2024-03-11 | Oleg Nodelman | 4.16M | 11.00% |
| 2024-03-11 | EcoR1 Capital, LLC | 4.16M | 11.00% |
| 2024-03-11 | EcoR1 Capital Fund Qualified, L.P. | 3.91M | 11.00% |
| 2024-02-13 | The Vanguard Group - 23-1945930 | 3.5M | 5.24% |
| 2024-02-09 | Abigail P. Johnson | 4.04M | 6.05% |
| 2024-02-09 | FMR LLC | 4.04M | 6.05% |
| 2024-01-24 | STATE STREET CORPORATION | 3.56M | 5.34% |
| 2023-09-18 | 2 | 3.72M | 5.60% |
| 2023-09-18 | 2 | 8752.0 | 12.00% |
| 2023-09-18 | 2 | 3.73M | 5.60% |
| 2023-09-18 | 2 | 3.72M | 5.60% |
| 2023-02-14 | ALEXANDER T. KARNAL | 3.47M | 6.45% |
| 2023-02-14 | BRIAN J. KREITER | 3.47M | 6.45% |
| 2023-02-14 | BRAIDWELL MANAGEMENT LLC | 3.47M | 6.45% |
| 2023-02-14 | BRAIDWELL LP | 3.47M | 6.45% |
| 2023-02-06 | Wellington Management Group LLP | 2.8M | 5.21% |
| 2023-02-06 | Wellington Group Holdings LLP | 2.8M | 5.21% |
| 2023-02-06 | Wellington Investment Advisors Holdings LLP | 2.8M | 5.21% |
| 2022-04-21 | Perceptive Life Sciences Master Fund, Ltd. | 5.33M | 10.00% |
| 2022-04-21 | Perceptive Advisors LLC | 5.33M | 10.00% |
| 2022-04-21 | Joseph Edelman | 5.33M | 10.00% |
| 2022-02-14 | Deep Track Capital, LP | 1.9M | 4.00% |
| 2022-02-14 | Deep Track Biotechnology Master Fund, Ltd. | 1.9M | 4.00% |
| 2022-02-14 | David Kroin | 1.9M | 4.00% |
| 2022-02-11 | OrbiMed Capital GP VI LLC | 2.71M | 5.70% |
| 2022-02-11 | Vivo Capital VIII, LLC | - | 0.00% |
| 2022-02-11 | OrbiMed Advisors LLC | 3.2M | 6.70% |
| 2022-02-11 | Versant Ophthalmic Affiliates Fund I, L.P. | 12092.0 | 0.00% |
| 2022-02-11 | Versant Venture Capital V (Canada) LP | 27399.0 | 0.10% |
| 2022-02-11 | GP-GP | 27399.0 | 0.10% |
| 2022-02-11 | Versant Ventures V (Canada), L.P. | 27399.0 | 0.10% |
| 2022-02-10 | R. Scott Struthers | 1.98M | 4.20% |
| 2022-02-11 | Versant Ventures V, LLC | 382.96K | 0.80% |
| 2022-02-11 | Versant Affiliates Fund V, L.P. | 10841.0 | 0.00% |
| 2022-02-11 | Versant Venture Capital V, L.P. | 360.03K | 0.80% |
| 2022-02-03 | (1) BlackRock, Inc. | 3.28M | 6.90% |
| 2022-01-10 | DRIEHAUS CAPITAL MANAGEMENT LLC | 4.79M | 10.09% |
| 2021-10-29 | BVF GP HOLDINGS LLC | 2.77M | 6.00% |
| 2021-10-29 | Biotechnology Value Fund, L.P. | 1.6M | 3.50% |
| 2021-10-29 | BVF I GP LLC | 1.6M | 3.50% |
| 2021-10-29 | Biotechnology Value Fund II, L.P. | 1.17M | 2.50% |
| 2021-10-29 | BVF II GP LLC | 1.17M | 2.50% |
| 2021-10-29 | Biotechnology Value Trading Fund OS LP | 178.66K | 1.00% |
| 2021-10-29 | BVF Partners OS Ltd. | 178.66K | 1.00% |
| 2021-10-29 | BVF Partners L.P. | 3M | 6.50% |
| 2021-10-29 | BVF Inc. | 3M | 6.50% |
| 2021-10-29 | Mark N. Lampert | 3M | 6.50% |
| 2021-04-22 | Deep Track Capital, LP | 1.9M | 5.05% |
| 2021-04-22 | Deep Track Biotechnology Master Fund, Ltd. | 1.9M | 5.05% |
| 2021-04-22 | David Kroin | 1.9M | 5.05% |
| 2021-02-16 | RA Capital Management, L.P. | 564.1K | 1.70% |
| 2021-02-16 | Peter Kolchinsky | 564.1K | 1.70% |
| 2021-02-16 | GP-GP | 135.61K | 0.40% |
| 2021-02-16 | Versant Ventures V (Canada), L.P. | 135.61K | 0.40% |
| 2021-02-16 | Versant Venture Capital V (Canada) LP | 135.61K | 0.40% |
| 2021-02-16 | Versant Venture Capital V, L.P. | 1.78M | 5.40% |
| 2021-02-12 | Vivo Capital LLC | 54711.0 | 0.20% |
| 2021-02-12 | Vivo Opportunity, LLC | 461.58K | 1.40% |
| 2021-02-12 | OrbiMed Capital GP VI LLC | - | 8.00% |
| 2021-02-16 | Versant Affiliates Fund V, L.P. | 53613.0 | 0.20% |
| 2021-02-16 | Versant Ophthalmic Affiliates Fund I, L.P. | 59437.0 | 0.20% |
| 2021-02-16 | Versant Ventures V, LLC | 1.9M | 5.80% |
| 2021-02-12 | OrbiMed Advisors LLC | 2.75M | 8.36% |
| 2021-02-12 | Vivo Capital VIII, LLC | 1.82M | 5.50% |
| 2021-02-05 | R. Scott Struthers | 1.7M | 5.10% |
| 2021-02-02 | (1) BlackRock, Inc. | 2.11M | 6.40% |
| 2020-06-11 | Vivo Capital LLC | 54711.0 | 0.20% |
| 2020-06-11 | Vivo Capital VIII, LLC | 2.24M | 6.80% |
| 2020-06-11 | Vivo Opportunity, LLC | 168.16K | 0.50% |
| 2020-04-20 | Perceptive Advisors LLC | 3.66M | 11.60% |
| 2020-04-20 | Ltd. | 3.66M | 11.60% |
| 2020-04-20 | Joseph Edelman | 3.66M | 11.60% |
| 2020-02-14 | OrbiMed Advisors LLC | 2.04M | 8.42% |
| 2020-02-14 | Capital GP VI LLC | 2.04M | 8.42% |
| 2020-02-13 | Vivo Capital LLC | 54711.0 | 0.20% |
| 2020-02-13 | Vivo Capital VIII, LLC | 3.1M | 12.80% |
| 2020-02-13 | Vivo Opportunity, LLC | 168.3K | 0.70% |
| 2020-02-11 | R. Scott Struthers | 1.5M | 6.10% |
| 2019-02-14 | Peter Kolchinsky | 1.88M | 7.80% |
| 2019-02-14 | RA Capital Management, LLC | 1.88M | 7.80% |
| 2018-07-30 | 5AM Ventures IV, L.P. | 3.36M | 14.60% |
| 2018-07-26 | Vivo Capital VIII, LLC | 3.44M | 14.40% |
| 2018-07-26 | Vivo Capital LLC | 54711.0 | 0.20% |
| 2018-07-26 | Vivo Opportunity, LLC | 294.36K | 1.20% |
CRNX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $46.55 | 94.06M | $4.38B | $101.54M | $48.54M | $4.33B |
| 2024-12-31 | $51.13 | 80.78M | $4.13B | $264.54M | $51.72M | $3.92B |
| 2023-12-31 | $35.58 | 58.07M | $2.07B | $54.9M | $51.73M | $2.06B |
| 2022-12-31 | $18.30 | 51.98M | $951.27M | $32.67M | $3.08M | $921.67M |
| 2021-12-31 | $28.41 | 38.44M | $1.09B | $200.7M | $4.01M | $895.28M |
| 2020-12-31 | $14.11 | 30.45M | $429.62M | $93.09M | $4.01M | $340.55M |
| 2019-12-31 | $25.09 | 24.18M | $606.55M | $40.33M | $5.57M | $571.8M |
| 2018-12-31 | $29.99 | 12.14M | $364.14M | $44.97M | -$ | $319.17M |
| 2017-12-31 | $24.51 | 13.88M | $340.15M | $14.19M | -$ | $325.96M |
| 2016-12-31 | $24.51 | 13.88M | $340.15M | $12.15M | $212K | $328.21M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36.32 | 104.1M | $3.78B | $114.34M | $47.86M | $3.71B |
| 2025-12-31 | $46.55 | 94.06M | $4.38B | $101.54M | $48.54M | $4.33B |
| 2025-09-30 | $41.65 | 94.22M | $3.92B | $110.9M | $49.14M | $3.86B |
| 2025-06-30 | $28.76 | 93.79M | $2.7B | $53.73M | $49.94M | $2.69B |
| 2025-03-31 | $33.54 | 93.1M | $3.12B | $94.57M | $50.82M | $3.08B |
| 2024-12-31 | $51.13 | 91.49M | $4.68B | $264.54M | $51.72M | $4.47B |
| 2024-09-30 | $51.10 | 80.09M | $4.09B | $317.27M | $52.54M | $3.83B |
| 2024-06-30 | $46.07 | 79.01M | $3.64B | $302.16M | $53.32M | $3.39B |
| 2024-03-31 | $46.53 | 72.29M | $3.36B | $395.92M | $52.5M | $3.02B |
| 2023-12-31 | $35.58 | 67.15M | $2.39B | $54.9M | $51.73M | $2.39B |
| 2023-09-30 | $29.74 | 56.81M | $1.69B | $142.8M | $52.17M | $1.6B |
| 2023-06-30 | $18.02 | 54.28M | $978.04M | $39.55M | $2.56M | $941.05M |